-Press release by Every Woman Treaty dated September 30, 2022 Every Woman, a coalition of more than 1,700 women's rights advocates in 128 countries, including India, has developed the findings-based draft instrument (Zero Draft EWT), informed by extensive consultation with experts from all regions of the world, including survivors, frontline activists, medical specialists, practitioners, scholars, human rights attorneys, and policy-makers. This Draft of global binding norm focuses on violence prevention and...

-Press release by by Alliance for Sustainable & Holistic Agriculture (ASHA-Kisan Swaraj) and the Right To Food Campaign (RTFC) dated June 20, 2022 Raipur/ New Delhi: Activists of Right to Food Campaign (RTFC) and Alliance for Sustainable & Holistic Agriculture (ASHA) urged the Chhattisgarh government to abandon its rice fortification interventions. They appealed to the state government that it should not get coerced into distributing fortified rice in the food schemes...

-Newsclick.in The high healthcare costs were expected to be addressed through the introduction of health insurance by the Union government, but it covers less than 30% of hospital charges leaving a heavy financial burden on the poor. Health outcomes have remained grossly unequal, with India's dalits and adivasis living shorter lives of poorer quality, as per a recent paper published by Oxfam India. Private infrastructure now accounts for nearly 62% of India's...

On Janaushadhi Diwas this year (i.e., March 7th, 2022), Prime Minister Shri Narendra Modi stated that the poor and the middle-class benefited from the 'Jan Aushadhi Kendras' that were set up to provide generic drugs at affordable prices. He said that the poor and the middle class saved around Rs.13,000 crore through these stores during the COVID-19 pandemic. In the wake of COVID 19 crisis, the 'Bureau of Pharma PSUs of India'...

-The Hindu The Health Ministry’s guidelines for managing COVID-19 ignore evidence, pricing, cost-effectiveness and social relevance. The Health Ministry released its first COVID-19 management guidelines about a year ago. The initial treatment guidelines included hydroxychloroquine, which led to panic buying of the drug. Little was known in those initial months. In the last one year, multiple studies have proven the lack of efficacy of hydroxychloroquine. While most practitioners have moved away from...